Assessing the cost-effectiveness of pharmacogenomics. [electronic resource]
Producer: 20020215Description: E29 p. digitalISSN:- 1522-1059
- Anticholesteremic Agents -- therapeutic use
- Anticoagulants -- pharmacokinetics
- Antimetabolites, Antineoplastic -- therapeutic use
- Cardiovascular Diseases -- drug therapy
- Carrier Proteins -- genetics
- Child
- Cholesterol Ester Transfer Proteins
- Cost-Benefit Analysis
- Drug Therapy -- economics
- Genotype
- Glycoproteins
- Hepatitis C -- drug therapy
- Humans
- Interferons -- therapeutic use
- Mercaptopurine -- therapeutic use
- Methyltransferases -- deficiency
- Pharmacogenetics -- economics
- Pharmacology, Clinical -- economics
- Phenotype
- Pravastatin -- therapeutic use
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Ribavirin -- therapeutic use
- Warfarin -- pharmacokinetics
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.